ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2022

A cost-utility analysis of apalutamide for metastatic castrationsensitive prostate cancer.

Ambica Parmar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.